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Chaihu, prepared from the dried roots of Bupleurum Chinense DC (also known as bei Chaihu in Chinese) or Bupleurum
scorzoneraefolium WILD (also known as nan Chaihu in Chinese), is a herbal medicine for harmonizing and soothing gan
(liver) qi stagnation. Substantial pharmacological studies have been conducted on Chaihu and its active components
(saikosaponins). One of the active components of Chaihu, saikosaponin-d, exhibited anticancer effects via autophagy
induction. This article reviews the pharmacological findings for the roles of autophagy in the pharmacological actions
of Chaihu and saikosaponins.
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Chaihu, prepared from the dried roots of Bupleurum
Chinense DC (also known as bei Chaihu in Chinese) or
Bupleurum scorzoneraefolium WILD (also known as nan
Chaihu in Chinese), is often prescribed as decoctions
such as “xiao yao powder”, “da Chaihu decoction”, or
“xiao Chaihu decoction” for treating chills and fevers
[1-3]. Chaihu facilitates sheng (ascending) and jiang
(dispersing) qi to alleviate stagnation of gan (liver) qi
[4]. The contemporary clinical indications for Chaihu
include common cold, malaria, cholecystitis, globus
pharyngitis, gynecological diseases, depression, hepatitis,
liver cirrhosis, pancreatitis, and hyperlipidemia [5,6]. Re-
cent research has revealed the pharmacological actions of
Chaihu. Specifically, Chaihu and its active components
(saikosaponins) exhibited immunomodulatory [7,8], anti-
viral [9], antipyretic [10,11], hepatoprotective [12,13],
anticancer [14], sedative, and analgesic [15] effects. Our
recent study further revealed that saikosaponin-a (Ssa)
and saikosaponin-d (Ssd), which are related to gan qi
regulation [4,13] can induce autophagy [16]. This article
reviews the recent findings for the roles of autophagy in* Correspondence: kawwong@must.edu.mo
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(Figure 1).
Chaihu regulates qi stagnation in Chinese Medicine (CM)
theory
The CM approach to relieving symptoms (e.g., physical
discomfort and emotional instability) is to soothe stagna-
tion of gan qi [17]. Gan qi stagnation can lead to (1) disten-
tion and pain in the chest and flank, and menstrual
dysregulation, (2) impaired digestive functions such as loss
of appetite, dyspepsia, flatulence, and regurgitation, and
(3) emotional instabilities such as depression, anxiety,
and insomnia [18]. Chaihu is often prescribed to relieve
the symptoms of qi stagnation in CM [5].
Modern pharmacological studies on Chaihu and its active
components
Chaihu alleviates a wide spectrum of disorders in a
multi-target manner through its immunomodulatory
[7], antipyretic [10], hepatoprotective [13], choleretic [15],
autophagy-inducing [16], sedative and analgesic [15], anti-
hyperlipidemic [15], antiviral [9], and anticancer [14]
effects.
The pharmacological effects of Chaihu are attributed to
its active components, Ssa, saikosaponin-c (Ssc), and Ssd
[19,20]. Ssa exhibits antiproliferative, anti-inflammatory,
anticancer, antioxidative, and hepatoprotective effects. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 A schematic diagram illustrating the pharmacological effects of Chaihu through autophagy induction. With its major clinical
indications in anti-inflammatory, anticancer, antifibrotic, antihyperlipidemic, and antipyretic functions, Chaihu exhibits its pharmacological
effects by regulating balanced cellular homeostasis via autophagy induction, leading to harmonization and modulation of qi in the
human body.
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proliferation, migration, and capillary vascularization
[27], and possesses anti-hepatitis effects [28]. Ssd also
exhibits immunomodulatory, antiproliferative, and an-
ticancer effects [29-32]. In particular, Ssd induces autoph-
agy and autophagic cell death in apoptosis-defective
cells via direct inhibition of sarcoplasmic/endoplasmic
reticulum Ca2+ ATPase pump (SERCA) and mammalian
target of rapamycin (mTOR), with disruption of calciumhomeostasis and induction of endoplasmic reticulum (ER)
stress [16].
Autophagy in health and diseases
Autophagy has been highlighted for its protective roles
in various physiological and pathological conditions in-
cluding (1) cellular homeostasis and genome stability
maintenance, (2) immunomodulation, (3) hepatoprotec-
tion and aggregate removal, (4) cancers, and (5) emotional
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mainly responsible for maintenance of normal cellular
and hormonal homeostasis, defense against pathogen
invasion, and protection against toxic protein aggregate
accumulation, and beneficial improvements in all of
these at the cellular level are related to improved qi
stagnation (Table 1).
Newborn mice under starvation showed immediate in-
creases of autophagy in various tissues, which returned
to the basal levels after nutrient supply restoration
[36-38]. Mice deficient in autophagy-related gene (Atg)
5 showed a substantial increase in nutrition deprivation-
induced death, suggesting an essential role of autophagy
in energy maintenance [39]. Autophagy is a protective
mechanism that eliminates abnormal proteins and de-
fective organelles such as mitochondria, peroxisomes, or
ER membranes. For example, hepatocytes from Atg7-
knockout mice exhibited accumulation of abnormal
mitochondria and ER structures [40], and associated
cellular degeneration [39]. A recent study further revealed
essential roles of autophagy in limiting DNA damage and
chromosome instability, and failure of the autophagy
process can result in carcinogenesis or cell death [41].
Chaihu-mediated autophagy induction
Maintenance of normal homeostasis by defense against
pathogen infections is critical. Fever is an immune re-
sponse initiated by inflammatory mediators such as
interleukin (IL)-1, IL-6, tumor necrosis factor (TNF)-α,
macrophage inflammatory protein 1, and interferon
(IFN) for heat production, and depends on antipyretics
(IL-10, glucocorticoids, and neuropeptides) for heat
dissipation [42,43]. Chaihu is prescribed as the major
herbal medicine to resolve alternating chills and fever,
headache, distention in the chest and flank, or loss of
appetite in CM [18,44]. Chaihu was reported to exert itsTable 1 Comparisons of CM applications, pharmacological ac
CM applications Pharmacological effect
Improvement of alternating chills and fever Antipyresis Antibacteria,
anti-endotoxin Immunom
Modulation of inflammatory symptoms and
diseases
Immunomodulation Anti
antivirus Modulation of c
Reduction of distention and pain in the chest
and flank Improvement of digestive functions:




Improvement of circulation or stasis of blood
and body fluid, and accumulation of phlegm
Promotion of cancer cell d
cancer cell proliferation Im
apoptosis, and anti-angiog
Improvement of emotional instability Reduction in plasma lipid
regulation Glucose metaantipyretic effect through the thermoregulatory center in
the hypothalamus [45]. Chaihu inhibited increases in
cyclic adenosine monophosphate (c-AMP), an endopyro-
gen, in the hypothalamus and promoted the release of
antipyretic substances [46]. Furthermore, total saikosa-
ponins exerted potent anti-endotoxin effects with a
simultaneous reduction in body temperature elevation
in vivo [47]. All of these beneficial effects can be attrib-
uted to the maintenance of cellular homeostasis, a key
process regulated by autophagy.
In liver ischemia-reperfusion injury, autophagy in-
duction attenuated the organ damage, and delayed in-
flammatory or oxidative damage [48]. Furthermore,
autophagy suppression was found to be a response to
excessive alcohol intake, which might be a reason for
the abnormal protein aggregation observed in liver
diseases [40]. In vitro studies further showed a dys-
function of autophagy in cells with hepatitis C virus
infection [48,49]. Autophagy was also found to regulate
the immunological responses to invading microorgan-
isms [50]. Another study showed that plasmacytoid
dendritic cells recognized viruses via Toll-like receptors
(TLRs) with a requirement for autophagy [51]. In addition,
defective autophagy was involved in inflammatory dis-
eases such as systemic lupus erythematosis and Crohn’s
disease [52,53]. Emerging evidence has suggested roles
for autophagy in immunological responses including
antimicrobial activity, antigen presentation, cytokine
production, and regulation of lymphocytes [50,54]. For
example, disruption of the virulence factor from the
HSV-1 virus, which inhibited the host autophagy pro-
teins, could prevent fatal encephalitis [55]. In addition,
autophagy exhibited protective functions in the spleen,
bone marrow, or liver through activation of immune re-
sponses such as detoxification and degradation of toxins









Immunomodulation by pathogen and cytokine
control Removal of abnormal protein aggregates





Cellular catabolism for removal of waste materials
Immunomodulation Anti-pathogens Removal of





Maintenance of genomic stability Promotion of
autophagic cell death Elimination of damaged
proteins and cytotoxic substances
levels Hormonal
bolism
Regulation of lipid metabolism Removal of toxic
mutant proteins and aggregates
Table 2 Chaihu-containing formulated decoctions
prescribed for modulation of cancers in CM [80]
Cancer Chaihu-containing prescriptions
Hepatocellular cancer Xiao Chaihu Decoction
Supplemented Da Chaihu Decoction
Si ni Powder combined with Liu jun zi Decoction
Supplemented Xiao yao Powder
No. 1 anticancer formula
Chaihu zhe chong Decoction
Experienced prescription
Pancreatic cancer Xiao Chaihu Decoction
Experienced prescription
Gall bladder cancer Shu gan li dan Decoction
Breast cancer Yi qi shu gan Decoction
Xiao ru Decoction
Supplemented Xiao yao powder combined
with Si jun zi Decoction
Experienced prescription
Cervical cancer Jia wei xiao yao Powder
Chaihu gui zhi Decoction
Thyroid carcinoma Jia xian ping Decoction
Esophageal carcinoma Jin fo yin
Er chen xuan fu Decoction
Gastric cancer Chaihu shu gan Decoction combined with
Xi shu jian
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vading pathogens by stimulating the secretion of gluco-
corticoids and inhibiting inflammation and anaphylaxis
[59,60], and was involved in inflammatory processes
such as infiltration, capillary permeability, and release of
cytokines [46]. Chaihu or its component saikosaponins
eliminated exogenous pyrogens through their antibac-
terial properties [61], and possessed antiviral activities
toward hepatitis B [62], human coronavirus 229E [9], in-
fluenza virus [11], and respiratory syncytial virus [63].
Ssd reduced the levels of cyclooxygenase and lipoxygen-
ase in vitro, promoted IL-2 and IL-4 production, and
inhibited IL-6, TNF-α, and IFN-γ expression in mouse T
lymphocytes [64,65]. The prominent anti-inflammatory
effects of Chaihu could be mediated through autophagy
induction, a key process for pathogen elimination and
immunity regulation. Our group was the first to report
the autophagic activities of Chaihu and Ssd [16]. We hy-
pothesized that Chaihu harmonizes the exterior and in-
terior of the human body and soothes gan qi stagnation
through autophagy induction.
Chaihu-induced autophagy alleviates gan qi stagnation
In CM theory, Chaihu soothes stagnation of gan qi
and promotes circulation of qi, and thus alleviates dis-
tention and pain in the chest and flank, menstrual
dysregulation, impaired digestive functions such as loss
of appetite, dyspepsia, flatulence, and regurgitation,
and emotional instabilities such as depression, anxiety,
and insomnia [18]. Chaihu is used to treat diseases re-
lated to the digestive system, e.g., hepatitis, liver cirrhosis,
cholecystitis, pancreatitis, gynecological diseases, and
hyperlipidemia [5].
Saikosaponins alleviated hepatocytes from oxidative
and inflammatory stresses, and inhibited liver fibrosis
[66]. Further studies demonstrated the protective effects
of saikosaponins in reducing lipid peroxidation in hepa-
tocytes [67], regulating intracellular calcium levels to
prevent hepatocyte injury [68], suppressing activation of
hepatic stellate cells as the major matrix-producing cells
in liver fibrosis [69,70], and reducing collagen I depos-
ition in the rat liver [71]. Saikosaponins exhibited regula-
tory effects on cytokines such as ILs, TNF, and IFN
[64,65], inhibitory effects on infiltration of macrophages
and T lymphocytes [72], and bidirectional modulation of
splenic T lymphocyte proliferation [64]. These findings
suggest that the hepatoprotective effects of Chaihu and
saikosaponins are related to improvement of gan qi stag-
nation. In addition to liver diseases, Chaihu is commonly
used for chronic pancreatitis [73]. Saikosaponins exhib-
ited potent stimulatory effects on pancreatic enzyme se-
cretion in rats [74]. Chai-hu-shu-gan powder inhibited
the expression of nuclear factor-κB (NF-κB) and TNF-α
mRNA in the pancreas to achieve anti-inflammatory andantifibrotic effects [75]. Moreover, the same prescription
reduced the abnormally high plasma level of cholecysto-
kinin in chronic pancreatitis, improved the gastric move-
ment, and avoided nausea and flatulence [76,77].
In liver ischemia-reperfusion injury, autophagy induc-
tion attenuated the ischemic and reperfusion damage to
the organ, probably because a decrease in autophagy
would lead to accumulation of dysfunctional mitochon-
dria, resulting in cellular damage and failure in energy
production, and eventually cell death [48]. In liver dis-
ease, suppression of autophagy caused abnormal protein
aggregation [40]. In liver fibrosis, autophagy activation
might be beneficial to the recovery of the liver function
[78]. All of these findings indicate that Chaihu-induced
autophagy might relieve liver disease-related symptoms
through anti-inflammatory, organ-protective, and aggre-
gate removal functions, which are related to alleviation
of gan qi stagnation.
Chaihu-mediated autophagy intervenes in carcinogenesis
In CM theory, tumor formation is the result of stasis of
xue (blood), retention of jin ye (fluid), and accumulation
of tan (phlegm) [79]. A recent study demonstrated
the anticancer effects of Ssa and Ssd via autophagy
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Chaihu is a commonly prescribed herb in contempor-
ary formulations (Table 2) with preventive or thera-
peutic effects on cancer [80]. Patients treated with
“xiao Chaihu” decoction exhibited a significantly lower
incidence of hepatocellular carcinoma [81], reductions
in cancer pain and tumor size [82,83], and prevention
of liver cancer relapses [84]. The decoction had mul-
tiple functions in immunomodulation, apoptosis, and
anti-angiogenesis [85-87].
The signaling pathway of autophagy is associated with
the key regulatory proteins of carcinogenesis, such as
tumor suppressor gene p53, phosphatase and tensin
homolog (PTEN), death-associated protein kinase, and
proto-oncoprotein B-cell CLL/lymphoma 2 (Bcl-2) [39,88].
Autophagy was responsible for massive cancer cell death
in vitro and in vivo [89-91]. Autophagic inducers also pro-
moted autophagic cell death in tumors or augmented
the efficacy of chemotherapeutic agents when used in
combination during cancer therapy [92,93]. By elimin-
ating genomic mutations, damaged proteins, and cyto-
toxic substances, autophagy protected cells against cancers
[94]. However, the roles of autophagy in cancers remain
controversial, because autophagy might promote tumor
growth by providing energy to poorly-vascularized tumor
cells [95].
Despite its adaptive and pro-survival roles, autophagy
can lead to type II programmed cell death [96]. Autoph-
agy promoted autophagic cell death in cells [97], and
killed apoptosis-resistant cancer cells under chemo-
therapy [98]. Moreover, autophagy was associated with
massive cancer cell death in cancerous tissues derived
from different organs [99,100]. Ssd was able to induce
autophagic cell death in a panel of apoptosis-resistant
cells via direct inhibition of SERCA [16]. The anticancer
effects of Chaihu can be attributed to its autophagy-
inducing ability.
Chaihu-mediated autophagy modulates stress
hormone-regulated metabolism
Chaihu could mediate its protective effects on gan qi
stagnation-induced emotional instability through lipid
metabolism and hormonal regulation [101]. In fact, ana-
lyses of plasma metabolites in a rat model of gan qi
stagnation stimulated by chronic immobilization stress
revealed elevated levels of lactic acid, saturated fatty
acid, and blood sugar, and reduced levels of unsaturated
fatty acid and high density lipoprotein [102]. Another
study applied stress to a macaque model with premenstrual
syndrome, and demonstrated increased plasma levels of
serotonin (5-HT), noradrenalin, and prolactin [103].
As a regulator of lipid and glucose metabolism [104],
loss of autophagy caused abnormal accumulation of
lipids in mouse hepatocytes and a significant increase inplasma triglycerides, with reductions in fatty acid beta-
oxidation [105] and pancreatic β-cell mass [106]. Co-
incidently, saikosaponins increased hepatic uptake of
cholesterol and decreased plasma levels of cholesterol
and triglycerides [107]. Furthermore, a study on depres-
sive patients revealed correlations between the plasma
levels of cholesterol, triglycerides, and serum neurotrans-
mitters, and depression [108]. As saikosaponins were able
to reduce the plasma levels of cholesterol, triglycerides,
and phospholipids [107], Chaihu might attenuate depres-
sive symptoms by regulating metabolite, hormone, and
neurotransmitter levels via autophagy-mediated lipid
metabolism in the human body.
Conclusions
The function of Chaihu in harmonizing the exterior and
interior of the body is related to its pathogen control
and immunomodulation properties. Furthermore, Chaihu’s
function in resolving gan qi stagnation might arise through
its supportive roles in protecting organs, preventing dam-
age to cells and organs, and restoring visceral and cellular
metabolic conditions. All of these protective pharmaco-
logical effects of Chaihu might be attributed to its autoph-
agy induction.
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